BTAL gained 19% in 2022 when the S&P 500 fell 18%. The fund lost 22.8% in 2025 while the S&P 500 gained 17.2%. Over the past decade BTAL declined 23% while the S&P 500 surged 241%. Are you ahead, or ...
Advances in the treatment of coronary artery disease remained steady in 2025, as in recent years, but the past 12 months also brought developments in novel areas, such as drug-coated balloons (DCBs), ...
Participants in the Android Beta Program get first dibs on the next update, which is set to land in official form next year Blake has over a decade of experience writing for the web, with a focus on ...
‘Marvel Tokon Fighting Souls’ has the heart and style of a great fighter, but its simplified mechanics leave more questions on the table for the full release than answers. Metroid Prime 4: Beyond ...
What if you could shape your creative vision with the precision of a sculptor, but instead of clay, you’re working with AI-generated art? Midjourney’s new Style Creator promises just that, a new tool ...
Apple’s iOS 26.2 beta 2 introduces a host of enhancements aimed at improving performance, extending battery life, and refining overall usability. First previewed at WWDC 2025, this update addresses ...
Help us pay for in-depth stories like this one by becoming a Seven Days Super Reader. One day in June, Beta Technologies founder Kyle Clark hopped into the cockpit of his company’s electric airplane ...
Everything new about the revamped Apple Vision Pro can fit in a single sentence: It has a far faster and more efficient M5 chip, it comes with a more comfortable Dual Knit Band and its display looks ...
For many in the crowd at Brooklyn Steel on Saturday, this may have been the most instrument-switching and most false-ending-filled show they’d ever seen. The Beta Band were gloriously weird in their ...
Since Pitchfork started publishing album reviews nearly 30 years ago, two things have remained constant: no comments section, and no second opinion. That is about to change. Coming in 2026, as ...
When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. “We commend [FCC} Chairman [Brendan] Carr for jump-starting the long-overdue 2022 Quadrennial ...
The Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for mitapivat in the treatment of adults with non-transfusion-dependent (NTD) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results